Alere Inc. News Headlines

ALR 
$40.69
*  
0.12
0.3%
Get ALR Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading ALR now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Meridian Bioscience Inc. (VIVO) Ex-Dividend Date Scheduled for January 29, 2015
1/28/2015 9:00:04 AM - NASDAQ.com News


Alere (ALR) Closes Alere Health Sale to Optum for $600M - Analyst Blog
1/12/2015 1:30:00 PM - Investopedia


Alere (ALR) Closes Alere Health Sale to Optum for $600M - Analyst Blog
1/12/2015 1:30:00 PM - Zacks.com


Alere To Present At J.P. Morgan Conference; Webcast At 10:30 AM ET
1/12/2015 9:30:00 AM - RTT News


Alere's (ALR) Influenza Test Gets CLIA Waiver from the FDA - Analyst Blog
1/7/2015 12:10:00 PM - Investopedia


Alere's (ALR) Influenza Test Gets CLIA Waiver from the FDA - Analyst Blog
1/7/2015 12:10:00 PM - Zacks.com


Steven Cohen’s Point72 Asset Management’s 3Q14 positions
12/18/2014 8:27:00 PM - Market Realist


Alere's HIV Combo Test Gets CLIA Waiver from the FDA - Analyst Blog
12/11/2014 12:20:00 PM - Zacks.com


Alere: FDA Grants CLIA Waiver For Alere Determine HIV-1/2 Ag/Ab Combo Test
12/9/2014 11:17:00 AM - RTT News


The Long Case For Alere
11/21/2014 10:37:00 AM - Seeking Alpha


Meridian Bioscience Inc. (VIVO) Ex-Dividend Date Scheduled for November 13, 2014
11/12/2014 9:00:04 AM - NASDAQ.com News


Alere (ALR) Lags Q3 Earnings, Revenues; Outlook Positive - Analyst Blog
10/29/2014 12:40:00 PM - Zacks.com


Walgreens Banks on Alliance Boots Deal, Headwinds Persist - Analyst Blog
10/28/2014 5:35:00 PM - Zacks.com


Abaxis Tops Q3 Earnings and Revenues, Margins Up Y/Y - Analyst Blog
10/22/2014 9:40:00 AM - Zacks.com


Baxter International Shows Stability on Top Line - Analyst Blog
10/21/2014 9:31:00 AM - Zacks.com


Baxter International Earnings Rise, Meet Estimates - Analyst Blog
10/20/2014 4:25:00 PM - Zacks.com


Mead Johnson Poised on Global Growth, R&D Initiatives - Analyst Blog
10/17/2014 4:25:00 PM - Zacks.com


Diamond Hill Capital Comments on Alere Inc
10/17/2014 4:24:16 PM - GuruFocus


Medtronic Initiates Enrollment for Pivotal Diabetes IDE Study - Analyst Blog
10/16/2014 2:20:00 PM - Zacks.com


Covidien (COV) in Focus: Stock Falls 7% - Tale of the Tape
10/16/2014 7:41:00 AM - Zacks.com


Notable Two Hundred Day Moving Average Cross - ALR
10/15/2014 10:42:12 AM - BNK Invest


Zimmer Expands Biologics Portfolio with ETEX Acquisition - Analyst Blog
10/8/2014 1:50:00 PM - Zacks.com


Update: Alere To Sell Health Management Business
10/8/2014 1:19:00 PM - Seeking Alpha


Hospira Gets FDA Warning Letter for Australian Facility - Analyst Blog
10/6/2014 4:55:00 PM - Zacks.com


Today In SA PRO: Wednesday, September 17
9/18/2014 5:00:00 AM - Seeking Alpha